What is the duration of action of tetracaine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Action of Tetracaine

Tetracaine has a duration of action of 30-60 minutes, with effects lasting up to 180-600 minutes in certain applications. 1

Pharmacological Properties of Tetracaine

Tetracaine is a potent ester-type local anesthetic agent with the following characteristics:

  • Onset of action:

    • For ophthalmic use: Maximum effect achieved within 10-20 seconds after instillation 2
    • For topical application: 1-5 minutes 1
  • Duration of action:

    • Standard duration: 30-60 minutes 1
    • Extended duration: 180-600 minutes (3-10 hours) when used for nerve blocks or infiltration 1
    • Ophthalmic use: 10-20 minutes for single application 2

Factors Affecting Duration

The duration of tetracaine's anesthetic effect can vary based on several factors:

  • Formulation: Different formulations can significantly affect duration
  • Concentration: Higher concentrations generally provide longer duration
  • Site of administration: Highly vascular areas may have shorter duration due to faster absorption
  • Use of vasoconstrictors: Addition of epinephrine can extend duration
  • Individual patient factors: Age, weight, and metabolism can affect duration

Comparative Duration with Other Local Anesthetics

When compared to other commonly used local anesthetics:

  • Tetracaine: 180-600 minutes (longest duration among ester anesthetics) 1
  • Lidocaine: 90-200 minutes 1
  • Proparacaine: Shorter duration than tetracaine for ophthalmic use 3

Clinical Applications

Ophthalmic Use

For ophthalmic procedures, tetracaine provides:

  • Maximum effect within 10-20 seconds
  • Duration of 10-20 minutes with a single application
  • Duration can be extended with repeated dosing 2
  • Demonstrated longer duration of action compared to proparacaine in corneal sensitivity studies 3

Intranasal Application

When used for nasal procedures:

  • Provides superior anesthesia compared to lidocaine
  • Effects still present at 70 minutes post-application 4

Extended Release Formulations

Microencapsulated tetracaine formulations have been developed to:

  • Increase duration of action up to 4-fold (approximately 40-60 minutes)
  • Provide immediate onset with extended effect throughout surgical procedures 5

Safety Considerations

When using tetracaine, be aware of:

  • Maximum safe dosage: 1-1.5 mg/kg without epinephrine 1
  • Potential for corneal toxicity: Prolonged use of topical ocular anesthetic may produce permanent corneal opacification and ulceration 2
  • Effect on intraocular pressure: May cause significant reduction in IOP after 15 minutes of application 6

Clinical Pearl

For procedures requiring longer anesthesia, consider:

  1. Using tetracaine for its longer duration compared to other ester anesthetics
  2. Repeated application to extend the duration (with caution regarding total dose)
  3. Alternative anesthetics like bupivacaine (180-600 minutes) if very long duration is needed 1

Tetracaine's duration of action makes it particularly suitable for short to medium-length procedures, with its extended duration in certain applications making it versatile across various clinical settings.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparison of Proparacaine, Tetracaine, and Oxybuprocaine in Corneal Sensitivity Measurement.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2024

Research

Intranasal anesthetic effects of lidocaine and tetracaine compared.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.